 | • レポートコード：QYR9NV18119 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、悪性腹水治療の世界市場について調査・分析し、悪性腹水治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（穿刺、化学療法、外科的治療）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の悪性腹水治療市場動向 ・主要企業別マーケットシェア ・悪性腹水治療の種類別市場規模2014-2019 （穿刺、化学療法、外科的治療） ・悪性腹水治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・悪性腹水治療の北米市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療の中国市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療の日本国内市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療のインド市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （PharmaCyte Biotech、Sequana Medical、BioVie、BD、GI Supply、Teva、Mylan、GE、Trion） ・悪性腹水治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Ascites Treatment development in North America, Europe and Asia-Pacific.
The key players covered in this study
PharmaCyte Biotech
Sequana Medical
BioVie
BD
GI Supply
Teva
Mylan
GE
Trion
Market segment by Type, the product can be split into
Paracentesis
Chemotherapy
Surgical Treatment
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific
The study objectives of this report are:
To analyze global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players.
To present the Malignant Ascites Treatment development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Malignant Ascites Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Malignant Ascites Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Paracentesis
1.4.3 Chemotherapy
1.4.4 Surgical Treatment
1.5 Market by Application
1.5.1 Global Malignant Ascites Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Malignant Ascites Treatment Market Size
2.2 Malignant Ascites Treatment Growth Trends by Regions
2.2.1 Malignant Ascites Treatment Market Size by Regions (2019-2025)
2.2.2 Malignant Ascites Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Malignant Ascites Treatment Market Size by by Players
3.1.1 Global Malignant Ascites Treatment Revenue by by Players (2014-2019)
3.1.2 Global Malignant Ascites Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Malignant Ascites Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Malignant Ascites Treatment Key Players Head office and Area Served
3.3 Key Players Malignant Ascites Treatment Product/Solution/Service
3.4 Date of Enter into Malignant Ascites Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Malignant Ascites Treatment Market Size by Type (2014-2019)
4.2 Global Malignant Ascites Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Malignant Ascites Treatment Market Size (2014-2019)
5.2 Malignant Ascites Treatment Key Players in North America
5.3 North America Malignant Ascites Treatment Market Size by Type
5.4 North America Malignant Ascites Treatment Market Size by Application
6 Europe
6.1 Europe Malignant Ascites Treatment Market Size (2014-2019)
6.2 Malignant Ascites Treatment Key Players in Europe
6.3 Europe Malignant Ascites Treatment Market Size by Type
6.4 Europe Malignant Ascites Treatment Market Size by Application
7 Asia-Pacific
7.1 Asia-Pacific Malignant Ascites Treatment Market Size (2014-2019)
7.2 Malignant Ascites Treatment Key Players in Asia-Pacific
7.3 Asia-Pacific Malignant Ascites Treatment Market Size by Type
7.4 Asia-Pacific Malignant Ascites Treatment Market Size by Application
8 International Players Profiles
8.1 PharmaCyte Biotech
8.1.1 PharmaCyte Biotech Company Details
8.1.2 Company Description and Business Overview
8.1.3 Malignant Ascites Treatment Introduction
8.1.4 PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2014-2019))
8.1.5 PharmaCyte Biotech Recent Development
8.2 Sequana Medical
8.2.1 Sequana Medical Company Details
8.2.2 Company Description and Business Overview
8.2.3 Malignant Ascites Treatment Introduction
8.2.4 Sequana Medical Revenue in Malignant Ascites Treatment Business (2014-2019)
8.2.5 Sequana Medical Recent Development
8.3 BioVie
8.3.1 BioVie Company Details
8.3.2 Company Description and Business Overview
8.3.3 Malignant Ascites Treatment Introduction
8.3.4 BioVie Revenue in Malignant Ascites Treatment Business (2014-2019)
8.3.5 BioVie Recent Development
8.4 BD
8.4.1 BD Company Details
8.4.2 Company Description and Business Overview
8.4.3 Malignant Ascites Treatment Introduction
8.4.4 BD Revenue in Malignant Ascites Treatment Business (2014-2019)
8.4.5 BD Recent Development
8.5 GI Supply
8.5.1 GI Supply Company Details
8.5.2 Company Description and Business Overview
8.5.3 Malignant Ascites Treatment Introduction
8.5.4 GI Supply Revenue in Malignant Ascites Treatment Business (2014-2019)
8.5.5 GI Supply Recent Development
8.6 Teva
8.6.1 Teva Company Details
8.6.2 Company Description and Business Overview
8.6.3 Malignant Ascites Treatment Introduction
8.6.4 Teva Revenue in Malignant Ascites Treatment Business (2014-2019)
8.6.5 Teva Recent Development
8.7 Mylan
8.7.1 Mylan Company Details
8.7.2 Company Description and Business Overview
8.7.3 Malignant Ascites Treatment Introduction
8.7.4 Mylan Revenue in Malignant Ascites Treatment Business (2014-2019)
8.7.5 Mylan Recent Development
8.8 GE
8.8.1 GE Company Details
8.8.2 Company Description and Business Overview
8.8.3 Malignant Ascites Treatment Introduction
8.8.4 GE Revenue in Malignant Ascites Treatment Business (2014-2019)
8.8.5 GE Recent Development
8.9 Trion
8.9.1 Trion Company Details
8.9.2 Company Description and Business Overview
8.9.3 Malignant Ascites Treatment Introduction
8.9.4 Trion Revenue in Malignant Ascites Treatment Business (2014-2019)
8.9.5 Trion Recent Development
9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific
10 Analyst’s Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details
Table Malignant Ascites Treatment Key Market Segments
Table Key Players Malignant Ascites Treatment Covered
Table Global Malignant Ascites Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Paracentesis Figures
Table Key Players of Paracentesis
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Surgical Treatment Figures
Table Key Players of Surgical Treatment
Table Global Malignant Ascites Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Malignant Ascites Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Malignant Ascites Treatment Report Years Considered
Figure Global Malignant Ascites Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Malignant Ascites Treatment Market Share by Regions 2014-2019
Figure Global Malignant Ascites Treatment Market Share by Regions 2014-2019
Figure Global Malignant Ascites Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Malignant Ascites Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Share by by Players (2014-2019)
Figure Global Malignant Ascites Treatment Market Share by by Players in 2018
Table Global Malignant Ascites Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Malignant Ascites Treatment Product/Solution/Service
Table Date of Enter into Malignant Ascites Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Malignant Ascites Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Size Share by Type (2014-2019)
Figure Global Malignant Ascites Treatment Market Size Market Share by Type (2014-2019)
Table Global Malignant Ascites Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Malignant Ascites Treatment Market Size Share by Application (2014-2019)
Figure Global Malignant Ascites Treatment Market Size Market Share by Application (2014-2019)
Figure Global Malignant Ascites Treatment Revenue Market Share by Application in 2018
Figure North America Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table North America Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Malignant Ascites Treatment Market Share by Type 2014-2019
Table North America Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Malignant Ascites Treatment Market Share by Application 2014-2019
Figure Europe Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table Europe Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Malignant Ascites Treatment Market Share by Type 2014-2019
Table Europe Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Malignant Ascites Treatment Market Share by Application 2014-2019
Figure Asia-Pacific Malignant Ascites Treatment Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Malignant Ascites Treatment Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Malignant Ascites Treatment Market Share (2018-2019)
Table Asia-Pacific Malignant Ascites Treatment Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Malignant Ascites Treatment Market Share by Type 2014-2019
Table Asia-Pacific Malignant Ascites Treatment Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Malignant Ascites Treatment Market Share by Application 2014-2019
Table PharmaCyte Biotech Company Details
Table PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure PharmaCyte Biotech Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table PharmaCyte Biotech Recent Development
Table Sequana Medical Company Details
Table Sequana Medical Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Sequana Medical Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Sequana Medical Recent Development
Table BioVie Company Details
Table BioVie Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure BioVie Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table BioVie Recent Development
Table BD Company Details
Table BD Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure BD Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table BD Recent Development
Table GI Supply Company Details
Table GI Supply Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure GI Supply Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table GI Supply Recent Development
Table Teva Company Details
Table Teva Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Teva Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Mylan Recent Development
Table GE Company Details
Table GE Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure GE Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table GE Recent Development
Table Trion Company Details
Table Trion Revenue in Malignant Ascites Treatment Business 2014-2019 (Million US$)
Figure Trion Revenue Growth Rate in Malignant Ascites Treatment Business (2014-2019)
Table Trion Recent Development
Table Global Malignant Ascites Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Malignant Ascites Treatment Market Size Share by Regions (2019-2025)
Figure Global Malignant Ascites Treatment Market Size Share by Regions in 2025
Figure North America Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Malignant Ascites Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Malignant Ascites Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Malignant Ascites Treatment Market Size by Product (2019-2025)
Figure Global Malignant Ascites Treatment Market Size by Product in 2025
Table Global Malignant Ascites Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Malignant Ascites Treatment Market Size by Application (2019-2025)
Figure Global Malignant Ascites Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
悪性腹水治療のグローバル市場：規模・現状・予測2019-2025 Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment mar…- 悪性腹水治療のグローバル市場：規模・現状・予測2019-2025 Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment mar…
- 悪性神経膠腫治療法のグローバル市場：規模・現状・予測2019-2025 Malignant glioma, a tumor derived from the nerve epithelium, is generally referred to as glioma, accounting for 40-50% of brain tumors, and is the most common intracranial malignant tumor.In 2018, the global Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx …
- 悪性神経膠腫治療法のグローバル市場：規模・現状・予測2019-2025 Malignant glioma, a tumor derived from the nerve epithelium, is generally referred to as glioma, accounting for 40-50% of brain tumors, and is the most common intracranial malignant tumor.In 2018, the global Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx …
- 悪性神経膠腫治療法のグローバル市場：規模・現状・予測2019-2025 Malignant glioma, a tumor derived from the nerve epithelium, is generally referred to as glioma, accounting for 40-50% of brain tumors, and is the most common intracranial malignant tumor.In 2018, the global Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx …